Clinical Trial Update: Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3 [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluating zoledronate for cervical intraepithelial neoplasia (CIN 2/3) or cervical cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Cervical Intraepithelial Neoplasia

Drugs mentioned

• Zoledronate (zoledronic acid)

Snippet

Sponsor: University of California, San Francisco | Conditions: Cervical Cancer, Precancerous Condition | Phase 1 | Status: TERMINATED